SHIELD THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.75 GBX | -5.41% |
|
+14.75% | -73.88% |
| May. 10 | Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Apr. 30 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
Evolution of the average Target Price on Shield Therapeutics plc
Price target over the last 5 years
History of analyst recommendation changes
57e5d15b.x2asNI_sFlYrI6oCAgoajdONTtjJ6Hi_ek4bo39ddBA.sg7Gf9ClJGETQZ1IMmRbv-PrKIj8gTTUGCpOwi8SRV-uHt5k7NRDEBhK_w~c1ad4361341a669bec42d5dbfd10d2b4
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.0175
GBP
Average target price
0.16
GBP
Spread / Average Target
+814.29%
High Price Target
0.3
GBP
Spread / Highest target
+1,614.29%
Low Price Target
0.02
GBP
Spread / Lowest Target
+14.29%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- STX Stock
- Consensus Shield Therapeutics plc